Clinically, TGF-β1 is often elevated in the plasma of patients with esophageal cancer (9), gastric cancer (10), osteosarcoma (11), melanoma (12), and increased serum TGF-β1 levels is related with poor prognosis (13,14). This evidence concerns the gene TGFB1 and esophageal cancer.